Viridian Therapeutics

$10.0M revenue • 40 employees • 221 Crescent St #103a, Waltham, MA, 02453, United States

Last Updated Feb 19, 2026

Company Overview

Company Name

Viridian Therapeutics

Address

221 Crescent St #103a, Waltham, MA, 02453, United States

Approx. Annual Revenue

$10.0M

Employees

40

Established

2019

About Viridian Therapeutics

Viridian Therapeutics is a United States-based company leveraging its expertise in antibody discovery to develop optimized treatments for rare autoimmune conditions. The company's focus includes thyroid eye disease and its FCRN portfolio, aiming to improve patient care through innovative therapeutics.

Business Profile

Read from the Viridian Therapeutics website on Oct 13, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
8/10 · Current copyright notice 2026; Complete pipeline and investor pages
Footer copyright year
2026

Biotech & Life Sciences Companies near Waltham, MA

Browse all Biotech & Life Sciences companies in Massachusetts →

Frequently Asked Questions about Viridian Therapeutics

Categories

Technologies Used

Social Profiles

Key Decision Makers

Steve Mahoney President
LinkedIn
Laura Epelbaum Director Clinical Operations
LinkedIn
Patrick Vittner Senior Clinical Trials Manager
LinkedIn
Lindsay Hodsdon Clinical Trial Manager
LinkedIn
Lindsay Toto Clinical Trial Manager
LinkedIn
Angela Doyle Sr. Clinical Trial Manager
LinkedIn